Iain Mattaj took office as director-general of the European Molecular Biology Laboratory on May 1, EMBL said last week. For the last five years, he was EMBL's scientific director.
David Cooper has been named senior vice president, finance, and treasurer at Agilent Technologies. Most recently, he was CFO of QRS, a collaborative services and software provider.
Mark Gardner has been promoted to chief marketing officer of Invitrogen, the company said this week. Most recently, he was Invitrogen's vice president of commercial marketing. Gardner holds a bachelor of science degree from the United States Naval Academy, a masters degree in international relations from Georgetown University, and an MBA from the Wharton School of Business at the University of Pennsylvania.
Timothy Haines has been named chief executive officer of Whatman, effective Sept. 1, the company said last week. He will join the company from Astex Technology, where he is CEO. Haines holds a BSc from Exeter University in the UK and an MBA from INSEAD. Haines will replace Tom McNally, who has held executive responsibilities at Whatman since January, when the company started to search for a new CEO. In 2006, McNally will return to his position as non-executive director of Whatman.
Vikram Jog has joined XDx as chief financial officer, a new position, the company said this week. Most recently, he was vice president of finance for Celera Genomics and Celera Diagnostics. Prior to this, he was vice president of planning and corporate controller for Applera. Jog received a bachelor of commerce degree from Delhi University in Delhi, India, and an MBA from Temple University in Philadelphia.
Joe Donahue has become corporate chief business officer and president of InforSense North America, the company said this week. He joins the company from Lion Bioscience, where he was most recently co-CEO. Prior to Lion, he was vice president of global life sciences and chemical markets at Spotfire. Donahue holds degrees in chemistry and computer science from Villanova University in Philadelphia.
Alex Kotzer will become president and chief executive officer of Compugen, starting in September, the Tel Aviv-based company said this week. Most recently, he was vice president at Serono of Geneva. Kotzer will replace president and CEO Mor Amitai, who said in October that he intended to resign before the end of 2005. Kotzer holds a BSc in chemical engineering from the Technion in Haifa, Israel.
Rosanne Coppola and Bruce Koepfgen have joined the board of directors of Fisher Scientific, the company said last week. Coppola is a director of M&F Worldwide, and Koepfgen is chief executive officer of Oppenheimer Capital.